Own-produced sales volumes rose by 8% for the third quarter relative to the same period last year, driven by 10% higher own-produced urea sales volumes. For the nine-month period ended 30 September 2023, the Company reported revenues of $1.8 billion, adjusted EBITDA of $715 million, adjusted net profit of $261 million, and free cash flows of $458 million. The short-term outlook is further underpinned by a strong order book for ammonia and urea sales in Q4 2023. We are pleased to note that our own-produced Q3 2023 sales volumes were up 8% year-on-year, primarily due to 10% higher own-produced urea sales volumes. As of 30 September 2023, Fertiglobe reported a net cash position of $28 million, compared to a net cash position of $287 million as of 31 December 2022, allowing it to continue balancing the pursuit of future growth opportunities with an attractive dividend pay-out.
